制药
Study in rats finds long-term omeprazole use disrupts mineral levels linked to anemia and bone health risks
由 AI 报道 AI 生成的图像 事实核查
Researchers in Brazil report that prolonged use of the proton pump inhibitor (PPI) omeprazole altered iron and calcium measures in adult rats and shifted how several minerals were distributed across organs—changes they say are consistent with higher risks of anemia and possible bone health harms. The authors and Brazil’s health regulator stress that PPIs remain effective for acid-related disorders, but warn against extended, unsupervised use.
Collegium Pharmaceutical, Inc. (COLL) held an investor conference call on March 19, 2026, to discuss its acquisition of AZSTARYS and relevant corporate subsidiaries from Corium Therapeutics. The deal aims to expand the company's position in the ADHD market. Executives including CEO Vikram Karnani joined the call.
由 AI 报道
Relmada Therapeutics, Inc. (RLMD) conducted its fourth quarter and full-year 2025 earnings conference call on March 19, 2026, at 4:30 PM EDT. The company released a press release detailing its business update and financial results for the periods ended December 31, 2025. Management highlighted forward-looking statements with associated risks.
Alkermes plc has published a slide deck accompanying its 2025 fourth-quarter earnings call. The materials were made available on February 25, 2026. This release provides insights into the company's financial performance for the period.
由 AI 报道
Sarepta Therapeutics, Inc. conducted its fourth quarter 2025 earnings call on February 25, 2026. The company released its financial results earlier that day, with details available on its website. Executives including CEO Douglas Ingram participated in the discussion.
Egypt's Minister of Health and Population Khaled Abdel Ghaffar met Kazakhstan's ambassador to Egypt, Askar Zhenis, to discuss strengthening bilateral cooperation in healthcare and pharmaceutical manufacturing technology. Abdel Ghaffar emphasized Egypt's interest in expanding ties through the transfer of pharmaceutical manufacturing technologies and harmonizing Good Manufacturing Practice standards. The talks covered collaboration in pharmaceutical production, biotechnology, and public health initiatives.
由 AI 报道
中国生物技术公司SciNeuro制药与瑞士制药巨头诺华周一宣布达成一项价值近17亿美元的合作协议，旨在开发治疗阿尔茨海默病的药物，该病影响全球约5500万人。 该协议授予诺华独家全球权利，开发和商业化SciNeuro的抗体候选物，以针对这种进行性脑部疾病。 SciNeuro的新型淀粉样蛋白β靶向抗体项目利用专有血脑屏障穿梭技术，帮助更多药物进入大脑发生阿尔茨海默病损伤的区域。
Egypt steps up research cooperation with Takeda
March 10, 2026 18:13Roche shares decline after giredestrant trial fails endpoint
March 05, 2026 02:11Clara Foods develops world's first animal-free pepsin
March 02, 2026 08:51Egypt unveils integrated plan to boost pharmaceutical and garments exports
March 01, 2026 03:28Collegium Pharmaceutical publishes Q4 2025 earnings presentation
February 17, 2026 01:32Farmacias similares begins expansion to japan
February 14, 2026 10:20Egypt offers WHO-certified expertise to boost Africa's medicine production
February 05, 2026 16:06特朗普推出折扣药网站后，日本药企股价下挫
January 30, 2026 21:57Australian sepsis drug advances in human trial
January 17, 2026 13:01Delhi high court allows cheaper cancer drug in India